Andrology and Urologic Health (AUH)

The Division of Andrology and Urologic Health is the leader, both within Michigan and across the nation, in treatment of benign prostatic hyperplasia, prostate cancer evaluation, treatment of peyronyes disease, erectile dysfunction and infertility.

The Division consists of four urology faculty members, three primary care faculty and two full-time physicians assistants who offer the entire spectrum of male and benign urologic care. The Division serves as the reference center for men seeking the latest treatments for benign prostate enlargement or innovative procedures such as UroLift and Histotripsy (soundwave oblative technology). AUH was also the first to offer injections for Peyrones disease along with other groundbreaking treatments for male sexual and reproductive concerns.

Meet the Team

Dana Alan Ohl, MD

Professor, Urology
Chief, Division of Andrology & Urologic Health, Urology
Hal Morgenstern, PhD

Hal Morgenstern, PhD

Professor Emeritus, Environmental Health Sciences
Professor Emeritus, Urology
Professor Emeritus, Epidemiology, School of Public Health
Karl Rew, M.D.

Karl T. Rew, M.D.

Associate Professor, Family Medicine and Urology
Clinical Lead for Outpatient Clinical Guidelines, Michigan Medicine Quality Department

Gary D. Smith, PhD

Professor, Molecular & Integrative Physiology
Professor, OB-Gyn
Professor, Urology
Director, MStem Cell Laboratories
Co-Director, Reproductive Sciences Program
John Thomas Wei MD

John Thomas Wei, MD

David A Bloom Professor of Urology
Medical Director of Brighton Center for Specialty Care